Oligonucleotide Synthesis: Global Strategic Business Report

Global Oligonucleotide Synthesis Market to Reach $19.9 Billion by 2030

The global market for Oligonucleotide Synthesis estimated at US$6.1 Billion in the year 2022, is projected to reach a revised size of US$19.9 Billion by 2030, growing at a CAGR of 15.9% over the analysis period 2022-2030. Oligonucleotide-Based Drugs, one of the segments analyzed in the report, is projected to record a 17.6% CAGR and reach US$8.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Synthesized Oligonucleotides segment is readjusted to a revised 15.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 21.5% CAGR

The Oligonucleotide Synthesis market in the U.S. is estimated at US$1.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2030 trailing a CAGR of 21.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.6% and 13.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2030.

Select Competitors (Total 41 Featured) -

• ATDBio Ltd.
• Bio-Synthesis Inc.
• Eurogentec
• GE Healthcare Life Sciences
• GeneDesign, Inc.
• GenScript Biotech Corporation
• Integrated DNA Technologies (IDT), Inc.
• LGC Biosearch Technologies
• Merck KgaA
• Nitto Denko Avecia Inc.
• Thermo Fisher Scientific, Inc.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year